Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sinovac Biotech Ltd (NASDAQ:SVA)

7.91
Delayed Data
As of Dec 12
 +0.03 / +0.38%
Today’s Change
4.60
Today|||52-Week Range
7.98
+34.07%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$449.3M

Company Description

Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacturing, and commercialization of pharmaceutical products. It operates through the Mainland China and Hong Kong geographical segments. It develops and markets human vaccines under the following brands: Inlive, Healive, Bilive, Anflu, PANFLU.1, and Panflu. The company was founded in 1993 and is headquartered in Beijing, China.

Contact Information

Sinovac Biotech Ltd.
No. 39 Shangdi Xi Road
Beijing Beijing 100085
P:861082890088
Investor Relations:
8610827998719659

Employees

Shareholders

Other institutional12.65%
Mutual fund holders0.24%
Individual stakeholders--

Top Executives

Wei Dong YinChairman, President, CEO & Secretary
Nan WangChief Financial Officer & Vice President
Qiang GaoVice President-Research & Development
Ming XiaVice President-Sales & Marketing
Helen G. YangHead-Investor Relations